The World of Health & Medicine News

WHO chief still hopes Trump administration will rethink withdrawal

WHO chief still hopes Trump administration will rethink withdrawal

The World Health Organization chief said on Thursday that he was still hoping the U.S. administration would reconsider its decision to withdraw from the organisation next month, saying that its exit would be a loss for the world.

In one of his first acts as U.S. president, Donald Trump signed the order to withdraw, saying the global health agency had mishandled the COVID-19 pandemic and was too close to China. It will take effect on Jan. 22, 2026.

The decision has raised concerns about global cooperation on any future outbreaks which the WHO helps coordinate through a series of international health regulations.

“There are things you can get only at the WHO and nowhere else. These issues are health security issues … and that’s why we were asking the U.S. to reconsider, because the world can only be secure if we are all in the same platform,” said WHO Director-General Tedros Adhanom Ghebreyesus in response to a reporter’s question about the withdrawal.

“Their absence from WHO is going to be a lose-lose, they will lose because of that. The rest of the world will also lose.”

Tedros said U.S. criticisms of the organisation were unwarranted since it was addressing them including through cost-cutting reforms. On the accusation of the mismanagement of the pandemic, he said lessons had been learned.

spot_img

Explore more

spot_img

8 Spices With More Anti-Inflammatory Benefits Than Turmeric

8 Spices With More Anti-Inflammatory Benefits Than Turmeric Certain spices can help reduce inflammation, a key factor in chronic conditions like diabetes and heart disease....

Sarepta’s Duchenne gene therapy slows disease progression, three-year data shows

Sarepta's Duchenne gene therapy slows disease progression, three-year data shows Sarepta Therapeutics' gene therapy for a muscle‑wasting disorder slowed disease progression and showed sustained benefit...

Lilly’s Zepbound plus Taltz boosts arthritis relief, weight loss in late-stage...

Lilly’s Zepbound plus Taltz boosts arthritis relief, weight loss in late-stage trial Eli Lilly (LLY.N), opens new tab said on Thursday a late-stage trial showed its weight-loss...

US withdraws from the World Health Organization

US withdraws from the World Health Organization The United States officially left the World Health Organization on Thursday after a year of warnings that doing...

This Popular Supplement May Help Inhibit Colorectal Cancer Development

This Popular Supplement May Help Inhibit Colorectal Cancer Development New clinical evidence indicates that a widely used supplement may alter gut microbes involved in vitamin...

Short, intensive workouts can help fight bowel cancer

Short, intensive workouts can help fight bowel cancer As many of us embark on an exercise or gym routine for the new year, research reveals...

Neuralink plans ‘high-volume’ brain implant production by 2026, Musk says

Neuralink plans 'high-volume' brain implant production by 2026, Musk says Elon Musk's brain implant company Neuralink will start "high-volume production" of brain-computer interface devices and...

Top 10 Scientists of 2025: Pioneers of Science and Innovation

Top 10 Scientists of 2025: Pioneers of Science and Innovation The prestigious scientific journal Nature publishes an annual list of ten outstanding individuals who have...